Abstract
The β-nitrostyrene family has been previously reported to possess anticancer property. However, the biological effects of β-nitrostyrenes on ovarian cancer and the underlying mechanisms involved remain unclear. In the present study, we synthesized a β-nitrostyrene derivative, CYT-Rx20 3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene), and investigated its anticancer effects and the putative pathways of action in ovarian cancer. The effects of CYT-Rx20 were analyzed using cell viability assay, reactive oxygen species (ROS) generation assay, FACS analysis, annexin V staining, immunostaining, comet assay, immunoblotting, soft agar assay, migration assay, nude mice xenograft study and immunohistochemistry. CYT-Rx20 induced cytotoxicity in ovarian cancer cells by promoting cell apoptosis via ROS generation and DNA damage. CYT-Rx20-induced cell apoptosis, ROS generation and DNA damage were reversed by thiol antioxidants. In addition, CYT-Rx20 inhibited ovarian cancer cell migration by regulating the expression of epithelial to mesenchymal transition (EMT) markers. In nude mice, CYT-Rx20 inhibited ovarian tumor growth accompanied by increased expression of DNA damage marker γH2AX and decreased expression of EMT marker Vimentin. CYT-Rx20 ...Continue Reading
References
Aug 1, 1997·Trends in Biochemical Sciences·D W Nicholson, N A Thornberry
Jun 16, 1999·Chemical Research in Toxicology·S BurneyS R Tannenbaum
Feb 23, 2002·Cell Death and Differentiation·J S ArmstrongS J Knox
Jun 18, 2002·Immunopharmacology and Immunotoxicology·K C CarterR Waddell
May 25, 2004·Journal of Cancer Research and Clinical Oncology·Xiaokui YangDing Ma
Nov 24, 2004·Biochemistry·Junguk Park, Dehua Pei
Jan 15, 2005·Antioxidants & Redox Signaling·Irfan RahmanH J Forman
Apr 5, 2007·Nature Protocols·Peggy L Olive, Judit P Banáth
Jul 3, 2007·Biochemical Pharmacology·Wei-Ya WangChin-Chung Wu
Mar 25, 2009·Biochimica Et Biophysica Acta·Angeliki Voulgari, Alexander Pintzas
Jul 11, 2009·Cancer Letters·Huei-Mei ChenShyng-Shiou Yuan
Sep 21, 2010·Bioorganic & Medicinal Chemistry·Pei-Wen HsiehChin-Chung Wu
Nov 3, 2010·DNA Repair·Simon Bekker-Jensen, Niels Mailand
Jul 20, 2011·Nature Chemical Biology·Bryan C Dickinson, Christopher J Chang
Dec 7, 2011·Journal of Ovarian Research·Cheryl A Sherman-BaustPatrice J Morin
Jan 13, 2012·Cell Death & Disease·M A KangT Ouchi
Mar 15, 2012·Endocrinology·Ignacio Romero, Robert C Bast
Mar 21, 2012·BMC Cancer·Alexandria M HaslehurstHarriet Feilotter
May 5, 2012·Seminars in Cancer Biology·Christina Scheel, Robert A Weinberg
Aug 24, 2012·Journal of the National Cancer Institute·Shyng-Shiou F YuanSteven Lo
Aug 29, 2012·Journal of Biomedicine & Biotechnology·Assim A Alfadda, Reem M Sallam
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jul 9, 2013·Biochimica Et Biophysica Acta·Paolo PaoliPaola Chiarugi
Oct 22, 2013·Genes & Development·Jeff H Tsai, Jing Yang
Nov 23, 2013·The Journal of Biological Chemistry·Yuan HeGabriel Núñez
Jan 11, 2014·Seminars in Cancer Biology·Ana CostaFatima Mechta-Grigoriou
Sep 13, 2014·European Journal of Medicinal Chemistry·Samira Rahmani-NezhadAbbas Shafiee
Oct 12, 2014·Current Opinion in Cell Biology·Colleen R Reczek, Navdeep S Chandel
Jan 17, 2015·Biochimie·I-Hua ChenChin-Chung Wu
Mar 22, 2015·Cancer Research·Zhiping ZengHu Zhou
Apr 4, 2015·Drug Design, Development and Therapy·Shu-Ting PanShu-Feng Zhou
Dec 20, 2015·Cancer Letters·Amos C HungShyng-Shiou F Yuan